Chevy Chase Trust Holdings, Inc. Care Dx, Inc. Transaction History
Chevy Chase Trust Holdings, Inc.
- $33.7 Billion
- Q2 2025
A detailed history of Chevy Chase Trust Holdings, Inc. transactions in Care Dx, Inc. stock. As of the latest transaction made, Chevy Chase Trust Holdings, Inc. holds 512,549 shares of CDNA stock, worth $6.14 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
512,549
Previous 535,341
4.26%
Holding current value
$6.14 Million
Previous $9.5 Million
5.4%
% of portfolio
0.03%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding CDNA
# of Institutions
229Shares Held
56.8MCall Options Held
51.2KPut Options Held
46K-
Black Rock Inc. New York, NY5.29MShares$63.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.83MShares$57.9 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA2.67MShares$31.9 Million0.01% of portfolio
-
State Street Corp Boston, MA2.48MShares$29.7 Million0.0% of portfolio
-
Bamco Inc New York, NY2.19MShares$26.2 Million0.12% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $640M
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...